Skinvisible (SKVI) Operating Expenses (2010 - 2026)
Skinvisible's (SKVI) quarterly Operating Expenses came in at $117817.0 in Q2 2026, down 16.58% year-over-year from $141237.0 in Q2 2025, and down 10.02% quarter-over-quarter from $130938.0 in Q1 2026.
Analysis
Skinvisible (SKVI) Operating Expenses (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Operating Expenses across 17 years of filings, most recently posting $117817.0 for Q2 2026.
- In Q2 2026, Operating Expenses fell 16.58% year-over-year to $117817.0; the TTM figure through Jun 2026 stood at $478981.0 (down 22.72% YoY), while the FY2025 annual figure was $516315.0, down 15.3% from the prior year.
- Operating Expenses came in at $117817.0 for Q2 2026 at Skinvisible, down from $130938.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $203743.0 in Q4 2024 to a low of $111057.0 in Q3 2025.
- Average Operating Expenses over 5 years is $133219.7, with a median of $130453.5 recorded in 2024.
- Year-over-year, Operating Expenses surged 43.95% in 2024 and plunged 41.51% in 2025.
- Over 5 years, Operating Expenses stood at $122716.0 in 2022, then grew by 15.34% to $141538.0 in 2023, then surged by 43.95% to $203743.0 in 2024, then tumbled by 41.51% to $119169.0 in 2025, then dropped by 1.13% to $117817.0 in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $117817.0 in Q2 2026, $130938.0 in Q1 2026, and $119169.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 117,817.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117,817.00 |
| Mar 31, 2026 | 130,938.00 |
| Dec 31, 2025 | 119,169.00 |
| Sep 30, 2025 | 111,057.00 |
| Jun 30, 2025 | 141,237.00 |
| Mar 31, 2025 | 144,852.00 |
| Dec 31, 2024 | 203,743.00 |
| Sep 30, 2024 | 129,969.00 |
| Jun 30, 2024 | 147,693.00 |
| Mar 31, 2024 | 128,184.00 |
| Dec 31, 2023 | 141,538.00 |
| Sep 30, 2023 | 118,110.00 |
| Jun 30, 2023 | 117,823.00 |
| Mar 31, 2023 | 132,904.00 |
| Dec 31, 2022 | 122,716.00 |
| Sep 30, 2022 | 133,183.00 |
| Jun 30, 2022 | 119,010.00 |
| Mar 31, 2022 | 138,011.00 |
| Dec 31, 2021 | 105,315.00 |
| Sep 30, 2021 | 119,274.00 |